1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MACROGENICS INC
Macrogenics Inc
XNAS: MGNX

Macrogenics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast...

Read More
3.00 -0.12 (-3.85%)
New 52W High in past week
1.0M
XNAS Volume
High vol.+gain this week

XNAS 13 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Macrogenics Inc is on 20 Mar 2026 for the purpose of Macrogenics Inc Fourth Quarter Earnings Results for 2025 See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
22.7 / 100
Momentum Score
Technically Bullish
78.1 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
4
1Yr Price target upside is 20%
5 analysts

21

S

8

W

1

O

3

T

SWOT Analysis

Macrogenics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..